Recently, Guo et al. validated the significant up-regulation of S100A8/A9 in animal models and patients [7], which supports our finding and highlights the contribution of S100A8/A9 to the pathogenesis of COVID-19. The gene discussed is IGKV1D-22; the disease is COVID-19.